Growth factors in induction of epithelial-mesenchymal transition and metastasis

Cells Tissues Organs

Volumn 193, Issue 1-2, 2010, Pages 85-97

  Said, Nur Akmarina B M ^a,b   Williams, Elizabeth D ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Cancer; Epithelial mesenchymal transition; Growth factor

Indexed keywords

CISPLATIN; CUSTIRSEN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; GEMCITABINE; HIGH MOBILITY GROUP A2 PROTEIN; INTEGRIN; JAGGED1; MITOGEN ACTIVATED PROTEIN KINASE; MITOXANTRONE; NOTCH RECEPTOR; P21 ACTIVATED KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SCATTER FACTOR; SOMATOMEDIN B; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; WNT PROTEIN;

ARTICLE; BREAST CANCER; CARCINOMA CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL MOTILITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TUMOR MICROENVIRONMENT;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS;

EID: 78650510303     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320360     Document Type: Article

References (106)

1. Adam, L., M. Zhong, W. Choi, W. Qi, M. Nicoloso, A. Arora, G. Calin, H. Wang, A. Siefker-Radtke, D. McConkey, M. Bar-Eli, C. Dinney (2009) miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 15:5060-5072.
2. Allington, T. M., W. P. Schiemann (2011) The cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells. Cells Tissues Organs 193:98-113.
3. Balzac, F., M. Avolio, S. Degani, I. Kaverina, M. Torti, L. Silengo, J. V. Small, S. F. Retta (2005) E-cadherin endocytosis regulates the activity of Rap1: a traffic light GTPase at the crossroads between cadherin and integrin function. J Cell Sci 118:4765-4783.
4. 1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12:27-36.
5. Bierie, B., H. L. Moses (2010) Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev 21:49-59.
6. Billottet, C, N. Elkhatib, J. P. Thiery, J. Jouanneau (2004) Targets of fibroblast growth factor 1 (FGF-1) and FGF-2 signaling involved in the invasive and tumorigenic behavior of carcinoma cells. Mol Biol Cell 15:4725-4734.
7. Bi llottet, C., M. Tuef ferd, D. Gent ien, A. Rapi nat, J. P. Thiery, P. Broet, J. Jouanneau (2008) Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells. J Cell Biochem 104:826-839.
8. Chaffer, C. L., J. P. Brennan, J. L. Slavin, T. Blick, E. W. Thompson, E. D. Williams (2006) Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66:11271-11278.
9. Chaffer, C. L., B. Dopheide, D. R. McCulloch, A. B. Lee, J. M. Moseley, E. W. Thompson, E. D. Williams (2005) Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis 22:115-125.
10. Chi, K. N., A. Zoubeidi, M. E. Gleave (2008) Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer. Expert Opin Investig Drugs 17:1955-1962.
11. Christiansen, J. J., A. K. Rajasekaran (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66:8319-8326.
12. Colomiere, M., A. C. Ward, C. Riley, M. K. Trenerry, D. Cameron-Smith, J. Findlay, L. Ackland, N. Ahmed (2009) Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br J Cancer 100:134-144.
13. Cowden Dahl, K. D., R. Dahl, J. N. Kruichak, L. G. Hudson (2009) The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia 11:1208-1215.
14. Das, S., B. N. Becker, F. M. Hoffmann, J. E. Mertz (2009) Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway. BMC Cell Biol 10:94.
15. Deckers, M., M. van Dinther, J. Buijs, I. Que, C. Lowik, G. van der Pluijm, P. ten Dijke (2006) The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66:2202-2209.
16. Del Castillo, G., M. M. Murillo, A. Alvarez-Barrientos, E. Bertran, M. Fernandez, A. Sanchez, I. Fabregat (2006) Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: role of EGF receptor ligands. Exp Cell Res 312:2860-2871.
17. Deng, Q. F., C. C. Zhou, C. X. Su (2009) Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial- mesenchymal transition in nonsmall cell lung cancer. Respirology 14:371-376.
18. Dissanayake, S. K., M. Wade, C. E. Johnson, M. P. O'Connell, P. D. Leotlela, A. D. French, K. V. Shah, K. J. Hewitt, D. T. Rosenthal, F. E. Indig, Y. Jiang, B. J. Nickoloff, D. D. Taub, J. M. Trent, R. T. Moon, M. Bittner, A. T. Weeraratna (2007) The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 282:17259-17271.
19. Doble, B. W., J. R. Woodgett (2007) Role of glycogen sy nthase kinase-3 in cell fate and epit helial-mesenchymal transitions. Cells Tissues Organs 185:73-84.
20. Eger, A., A. Stockinger, J. Park, E. Langkopf, M. Mikula, J. Gotzmann, W. Mikulits, H. Beug, R. Foisner (2004) Beta-catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 23:2672-2680.
21. Fischer, A. N., E. Fuchs, M. M ikula, H. Huber, H. Beug, W. Mikulits (2007) PDGF essentially links TGF-beta signaling to nuclear betacatenin accumulation in hepatocellular carcinoma progression. Oncogene 26:3395-3405.
22. Fuchs, B. C., T. Fujii, J. D. Dorfman, J. M. Goodwin, A. X. Zhu, M. Lanuti, K. K. Tanabe (2008) Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 68:2391-2399.
23. Giannelli, G., C. Bergamini, E. Fransvea, C. Sgarra, S. Antonaci (2005) Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 129:1375-1383.
24. Gotzmann, J., A. N. Fischer, M. Zojer, M. Mikula, V. Proell, H. Huber, M. Jechlinger, T. Waerner, A. Weith, H. Beug, W. M ikulits (2006) A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene 25:3170-3185.
25. Graham, T. R., H. E. Zhau, V. A. Odero-Marah, A. O. Osunkoya, K. S. Kimbro, M. Tighiouart, T. Liu, J. W. Simons, R. M. O'Regan (2008) Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelialto-mesenchymal transition in human prostate cancer cells. Cancer Res 68:2479-2488.
26. Gregory, P. A., A. G. Bert, E. L. Paterson, S. C. Barry, A. Tsykin, G. Farshid, M. A. Vadas, Y. Khew-Goodall, G. J. Goodall (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593-601.
27. Grotegut, S., D. von Schweinitz, G. Christofori, F. Lehembre (2006) Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 25:3534-3545.
28. Hajra, K. M., E. R. Fearon (2002) Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34:255-268.
29. Helleman, J., M. P. Jansen, C. Burger, M. E. van der Burg, E. M. Berns (2010) Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGF-beta and regulating microRNAs. Int J Biochem Cell Biol 42:25-30.
30. Huber, M. A., N. Kraut, H. Beug (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17:548-558.
31. Hugo, H., M. L. Ackland, T. Blick, M. G. Lawrence, J. A. Clements, E. D. Williams, E. W. Thompson (2007) Epithelial-mesenchymal and mesenchymal- epithelial transitions in carcinoma progression. J Cell Physiol 213:374-383.
32. Ii, M., H. Yamamoto, Y. Adachi, Y. Maruyama, Y. Shinomura (2006) Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231:20-27.
33. Illman, S. A., K. Lehti, J. Keski-Oja, J. Lohi (2006) Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J Cell Sci 119:3856-3865.
34. Imamichi, Y., A. Menke (2007) Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition. Cells Tissues Organs 185:180-190.
35. Isohata, N., K. Aoyagi, T. Mabuchi, H. Daiko, M. Fukaya, H. Ohta, K. Ogawa, T. Yoshida, H. Sasaki (2009) Hedgehog and epithelial-mesenchymal transition signaling in normal and malignant epithelial cells of the esophagus. Int J Cancer 125:1212-1221.
36. Jones, R. A., C. I. Campbell, G. A. Wood, J. J. Petrik, R. A. Moorehead (2009) Reversibility and recurrence of IGF-IR-induced mammary tumors. Oncogene 28:2152-2162.
37. Jorda, M., D. Olmeda, A. Vinyals, E. Valero, E. Cubillo, A. Llorens, A. Cano, A. Fabra (2005) Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci 118:3371-3385.
38. Joseph, M. J., S. Dangi-Garimella, M. A. Shields, M. E. Diamond, L. Sun, J. E. Koblinski, H. G. Munshi (2009) Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells. J Cell Biochem 108:726-736.
39. Kalluri, R., R. A. Weinberg (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428.
40. Kasper, M., H. Schnidar, G. W. Neill, M. Hanneder, S. Klingler, L. Blaas, C. Schmid, C. Hauser-Kronberger, G. Regl, M. P. Philpott, F. Aberger (2006) Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocy tes. Mol Cell Biol 26:6283-6298.
41. Katoh, M. (2005) Epithelial-mesenchymal transition in gastric cancer (review). Int J Oncol 27:1677-1683.
42. Katoh, M. (2006) Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 5:1059-1064.
43. Katoh, Y., M. Katoh (2009) FGFR2-related pathogenesis and FGFR2-targeted therapeutics (rev iew). Int J Mol Med 23:307-311.
44. Kim, H. J., B. C. Litzenburger, X. Cui, D. A. Delgado, B. C. Grabiner, X. Lin, M. T. Lewis, M. M. Gottardis, T. W. Wong, R. M. Attar, J. M. Carboni, A. V. Lee (2007) Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelialto-mesenchymal transition mediated by NF-kappaB and snail. Mol Cell Biol 27:3165-3175.
45. Kong, D., Y. Li, Z. Wang, S. Banerjee, A. Ahmad, H. R. Kim, F. H. Sarkar (2009) miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27:1712-1721.
46. Kong, D., Z. Wang, S. H. Sarkar, Y. Li, S. Banerjee, A. Saliganan, H. R. Kim, M. L. Cher, F. H. Sarkar (2008a) Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells 26:1425-1435.
47. Kong, W., H. Yang, L. He, J. J. Zhao, D. Coppola, W. S. Dalton, J. Q. Cheng (2008b) Micro-RNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28:6773-6784.
48. Kowanetz, M., U. Valcourt, R. Bergstrom, C. H. Heldin, A. Moustakas (2004) Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 24:4241-4254.
49. Lenferink, A. E., C. Cantin, A. Nantel, E. Wang, Y. Durocher, M. Banville, B. Paul-Roc, A. Marcil, M. R. Wilson, M. D. O'Connor-Mc-Court (2010) Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies. Oncogene 29:831-844.
50. Leong, K. G., K. Niessen, I. Kulic, A. Raouf, C. Eaves, I. Pollet, A. Karsan (2007) Jagged1-mediated Notch activation induces epithelial-to- mesenchymal transition through Sluginduced repression of E-cadherin. J Exp Med 204:2935-2948.
51. Li, Y., K. Yang, Q. Mao, X. Zheng, D. Kong, L. Xie (2010) Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase. Int Urol Nephrol 42:315-323.
52. Li, F., Y. Zhang, C. Wu (1999) Integrin-linked kinase is localized to cell-matrix focal adhesions but not cell-cell adhesion sites and the focal adhesion localization of integrinlinked kinase is regulated by the PINCH-binding ANK repeats. J Cell Sci 112:4589-4599.
53. Lo, H. W., S. C. Hsu, W. Xia, X. Cao, J. Y. Shih, Y. Wei, J. L. Abbruzzese, G. N. Hortobagyi, M. C. Hung (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67:9066-9076.
54. Lorch, J. H., J. Klessner, J. K. Park, S. Getsios, Y. L. Wu, M. S. Stack, K. J. Green (2004) Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 279:37191-37200.
55. Lu, Z., S. Ghosh, Z. Wang, T. Hunter (2003) Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of betacatenin, and enhanced tumor cell invasion. Cancer Cell 4:499-515.
56. McPhee, T. R., P. C. McDonald, A. Oloumi, S. Dedhar (2008) Integrin-linked kinase regulates E-cadherin expression through PARP-1. Dev Dyn 237:2737-2747.
57. Medici, D., A. Nawshad (2010) Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-kappaB and LEF-1. Matrix Biol 26:161-165.
58. Michl, P., A. R. Ramjaun, O. E. Pardo, P. H. Wa rne, M. Wagner, R. Poulsom, C. D'Arr igo, K. Ryder, A. Menke, T. Gress, J. Downward (2005) CUTL1 is a target of TGF (beta) signaling t hat enhancescancer cell motility and invasiveness. Cancer Cell 7:521-532.
59. Mimeault, M., S. K. Batra (2007) Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann Oncol 18:1605-1619.
60. Mimeault, M., E. Moore, N. Moniaux, J. P. Henichart, P. Depreux, M. F. Lin, S. K. Batra (2006) Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells. Int J Cancer 118:1022-1031.
61. Miyake, H., I. Hara, M. Fujisawa, M. E. Gleave (2006) The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer. Expert Opin Investig Drugs 15:507-517.
62. Miyazono, K. (2009) Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci 85:314-323.
63. Morali, O. G., V. Delmas, R. Moore, C. Jeanney, J. P. Thiery, L. Larue (2001) IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20:4942-4950.
64. Moustakas, A., C. H. Heldin (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98:1512-1520.
65. Murillo, M. M., G. del Castillo, A. Sanchez, M. Fernandez, I. Fabregat (2005) Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes. Oncogene 24:4580-4587.
66. Nakaya, Y., G. Sheng (2008) Epithelial to mesenchymal transition during gastrulation: an embryological view. Dev Growth Differ 50:755-766.
67. Nakaya, Y., E. W. Sukowati, C. Alev, F. Nakazawa, G. Sheng (2011) Involvement of dystroglycan in epithelial-mesenchymal transition during chick gastrulation. Cells Tissues Organs 193:64-73.
68. Ozdamar, B., et al (2005) Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity. Science 307:1603-1609.
69. Peinado, H., M. Quintanilla, A. Cano (2003) Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 278:21113-21123.
70. Pennisi, P.A., V. Barr, N. P. Nunez, B. Stannard, D. Le Roith (2002) Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype. Cancer Res 62:6529-6537.
71. Perez-Moreno, M. A., A. Locascio, I. Rodrigo, G. Dhondt, F. Portillo, M. A. Nieto, A. Cano (2001) A new role for E12/E47 in the repression of E-cadherin expression and epithelialmesenchymal transitions. J Biol Chem 276:27424-27431.
72. Prunier, C, PH. Howe (2005) Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT). J Biol Chem 280:17540-17548.
73. Radisky, D. C., D. D. Levy, L. E. Littlepage, H. Liu, CM. Nelson, J. E. Fata, D. Leake, E. L. Godden, D. G Albertson, M. A. Nieto, Z. Werb, M. J. Bissell (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436:123-127.
74. Rodgers, U. R., L. Kevorkian, A. K. Surridge, J. G. Waters, T. E. Swingler, K. Culley, S. Illman, J. Lohi, A. E. Parker, I. M. Clark (2009) Expression and function of matrix metalloproteinase (MMP)-28. Matrix Biol 28:263-272.
75. Royal, I., N. Lamarche-Vane, L. Lamorte, K. Kaibuchi, M. Park (2000) Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol Biol Cell 11:1709-1725.
76. Schickel, R., S. M. Park, A. E. Murmann, M. E. Peter miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol Cell 38:908-915.
77. Shintani, Y., M. Maeda, N. Chaika, K. R. Johnson, M. J. Wheelock (2008) Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. Am J Respir Cell Mol Biol 38:95-104.
78. Srivastava, S., B. Ramdass, S. Nagarajan, M. Rehman, G Mukherjee, S. Krishna (2010) Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression. Br J Cancer 102:196-205.
79. Sun, X., J. D. Ritzenthaler, K. Wang, X. Zhong, E. S. White, S. Han, J. Roman (2010) The fibronectin EDA splicing variant induces epithelial-mesenchymal transition in lung cancer cells through integrin {alpha}9{beta} 1-mediated activation of PI3-K and Erk. Am J Physiol Lung Cell Mol Physiol, Epub ahead of print.
80. Taki, M., K. Verschueren, K. Yokoyama, M. Nagayama, N. Kamata (2006) Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelialmesenchymal transition in human squamous carcinoma cells. Int J Oncol 28:487-496.
81. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
82. Thiery, J. P. (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746.
83. Thiery, J. P., J. P. Sleeman (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142.
84. Thomson, S., F. Petti, I. Sujka-Kwok, D. Epstein, J. D. Haley (2008) Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Clin Exp Metastasis 25:843-854.
85. Thuault, S., U. Valcourt, M. Petersen, G. Manfioletti, C. H. Heldin, A. Moustakas (2006) Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174:175-183.
86. Tian, M., W. P. Schiemann (2009) The TGF-beta paradox in human cancer: an update. Future Oncol 5:259-271.
87. Timmerman, L. A., J. Grego-Bessa, A. Raya, E. Bertran, J. M. Perez-Pomares, J. Diez, S. Aranda, S. Palomo, F. McCormick, J. C. Izpisua-Belmonte, J. L. de la Pompa (2004) Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18:99-115.
88. Tryndyak, V. P., F. A. Beland, I. P. Pogribny (2010) E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer 126:2575-2583.
89. Tulasne, D., R. Paumelle, K. M. Weidner, B. Vandenbunder, V. Fafeur (1999) The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol Biol Cell 10:551-565.
90. Valles, A. M., B. Boyer, G. Tarone, J. P. Thiery (1996) Alpha 2 beta 1 integrin is required for the collagen and FGF-1 induced cell dispersion in a rat bladder carcinoma cell line. Cell Adhes Commun 4:187-199.
91. Vandewalle, C, J. Comijn, B. De Craene, P. Vermassen, E. Bruyneel, H. Andersen, E. Tulchinsky, F. Van Roy, G. Berx (2005) SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 33:6566-6578.
92. Varnat, F., A. Duquet, M. Malerba, M. Zbinden, C. Mas, P. Gervaz, A. Ruiz i Altaba (2009) Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 1:338-351.
93. Verschueren, K., J. E. Remacle, C. Collart, H. Kraft, B. S. Baker, P. Tylzanowski, L. Nelles, G. Wuytens, M. T. Su, R. Bodmer, J. C. Smith, D. Huylebroeck (1999) SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes. J Biol Chem 274:20489-20498.
94. Vincent, T., E. P. Neve, J. R. Johnson, A. Kukalev, F. Rojo, J. Albanell, K. Pietras, I. Virtanen, L. Philipson, P. L. Leopold, R. G Crystal, A. G. de Herreros, A. Moustakas, R. F. Pettersson, J. Fuxe (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 11:943-950.
95. Waerner, T., M. Alacakaptan, I. Tamir, R. Oberauer, A. Gal, T. Brabletz, M. Schreiber, M. Jechlinger, H. Beug (2006) ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 10:227-239.
96. Wang, Z., S. Sandiford, C. Wu, S. S. Li (2009) Numb regulates cell-cell adhesion and polarity in response to tyrosine kinase signalling. EMBO J 28:2360-2373.
97. Wilkins-Port, C. E., P. J. Higgins (2007) Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes. Cells Tissues Organs 185:116-122.
98. Wyatt, L., Y. Khew-Goodall (2008) PTP-Pez: a novel regulator of TGFbeta signaling. Cell Cycle 7:2290-2295.
99. Wyatt, L., C. Wadham, L. A. Crocker, M. Lardelli, Y. Khew-Goodall (2007) The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development. J Cell Biol 178:1223-1235.
100. Yang, L., C. Lin, Z. R. Liu (2006) P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin. Cell 127:139-155.
101. Yates, C. C., C. R. Shepard, D. B. Stolz, A. Wells (2007) Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96:1246-1252.
102. Yokoyama, K., N. Kamata, R. Fujimoto, S. Tsutsumi, M. Tomonari, M. Taki, H. Hosokawa, M. Nagayama (2003) Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int J Oncol 22:891-898.
103. Yook, J. I., X. Y. Li, I. Ota, C. Hu, H. S. Kim, N. H. Kim, S. Y. Cha, J. K. Ryu, Y. J. Choi, J. Kim, E. R. Fearon, S. J. Weiss (2006) A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 8:1398-1406.
104. Zavadil, J., L. Cermak, N. Soto-Nieves, E. P. Bottinger (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelialto-mesenchymal transition. EMBO J 23:1155-1165.
105. Zeineldin, R., R. Martina, O. Dominic (2006) Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III. Mol Carcinog 45:851-860.
106. Zhang, D., T. A. LaFortune, S. Krishnamurthy, F. J. Esteva, M. Cristofanilli, P. Liu, A. Lucci, B. Singh, M. C. Hung, G. N. Hortobagyi, N. T. Ueno (2009) Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer. Clin Cancer Res 15:6639-6648.